Clinical Trial Update: The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether omalizumab affects airway responsiveness to adenosine in patients with poorly controlled asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Xolair (omalizumab)

Snippet

Sponsor: University of Florida | Conditions: Asthma | Phase 4 | Status: COMPLETED